Please assess the completion status of the following clinical trial:

Trial Title: Effect of Preoperative Buccal Misoprostol on Blood Loss in Second-trimester Dilation and Evacuation Abortion

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* English or Spanish speaking~* Gestational age between 16 weeks 6 days and 20 weeks 6 days gestation by ultrasound dating on the day of enrollment~* Ultrasound used for dating purposes must be within the last two weeks.~* Women 18-50 years of age undergoing surgical termination of pregnancy~Exclusion Criteria:~* Spontaneous fetal demise~* Ruptured membranes or intrauterine infection~* Fibroids that significantly distort the uterine shape~* Uterine abnormality such as unicornuate uterus~* Prior transmural myomectomy~* Severe oligohydramnios~* Morbid obesity with BMI\>45~* Inability to place osmotic dilators

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Misoprostol (Type: ACTIVE_COMPARATOR): 400 mcg buccally 2 hours prior to procedure
- Placebo (Folic acid) (Type: PLACEBO_COMPARATOR): Two 1-mg tablets buccally 2 hours prior to procedure

Based on this trial design, predict the completion outcome and termination type (if applicable).